Tradewind BioScience

Tradewind translates scientific insight into innovative ways of…

San Francisco, United States · Founded 2017

Employees
1–10
Founded
2017
Last Round
GrantMar 2021
Rounds
1

About

Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.

Summary

Tradewind BioScience is a Healthcare company based in San Francisco, United States, founded in 2017. Its most recent funding was a Grant round in Mar 2021. Investors include Department of Health and Human Services.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

GrantMar 2021

Investors

Similar Companies